These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 24671916)
1. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy. Dąbrowski R; Opolski G; Włodarczyk P; Kiliszek M; Ponikowski P Kardiol Pol; 2014; 72(8):700-6. PubMed ID: 24671916 [TBL] [Abstract][Full Text] [Related]
2. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland. Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513 [TBL] [Abstract][Full Text] [Related]
3. Cardioversion differences among first detected episode, paroxysmal, and persistent atrial fibrillation patients in the RHYTHM AF registry in Poland. Kiliszek M; Opolski G; Włodarczyk P; Ponikowski P Cardiol J; 2015; 22(4):453-8. PubMed ID: 25588533 [TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF). Opolski G; Kosior DA; Kurzelewski M; Skrzyńska M; Zagórski A; Janion M; Muzolf M; Wlazłowski R; Pankiewicz B; Łoboz-Grudzień K; Breithardt G; Kardiol Pol; 2010 May; 68(5):546-54. PubMed ID: 20491018 [TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Pisters R; Nieuwlaat R; Prins MH; Le Heuzey JY; Maggioni AP; Camm AJ; Crijns HJ; Europace; 2012 May; 14(5):666-74. PubMed ID: 22223715 [TBL] [Abstract][Full Text] [Related]
6. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088 [TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study. Lopes RD; de Paola AA; Lorga Filho AM; Consolim-Colombo FM; Andrade J; Piva E Mattos LA; Bernardez-Pereira S; Berwanger O; de Oliveira Figueiredo MJ; Am Heart J; 2016 Jun; 176():10-6. PubMed ID: 27264215 [TBL] [Abstract][Full Text] [Related]
8. Persistent atrial fibrillation: a population based study of patients with their first cardioversion. Lehto M; Kala R Int J Cardiol; 2003 Dec; 92(2-3):145-50. PubMed ID: 14659845 [TBL] [Abstract][Full Text] [Related]
9. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation. Rajagopalan B; Curtis AB Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136 [TBL] [Abstract][Full Text] [Related]
10. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B; Opolski G Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [TBL] [Abstract][Full Text] [Related]
11. Chronicity of atrial fibrillation affects duration of sinus rhythm after transthoracic cardioversion of dogs with naturally occurring atrial fibrillation. Bright JM; zumBrunnen J J Vet Intern Med; 2008; 22(1):114-9. PubMed ID: 18289297 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation. Wozakowska-Kapłon B; Opolski G; Janion M Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556 [TBL] [Abstract][Full Text] [Related]
14. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation. Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817 [TBL] [Abstract][Full Text] [Related]
15. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472 [TBL] [Abstract][Full Text] [Related]
16. Cardioversion in recent onset atrial fibrillation. Fernández de Simón A; Coll-Vinent B; Martín A; Suero C; Sánchez J; Varona M; Sánchez S; Cancio M; Carbajosa J; Malagón F; Montull E; Del Arco C Emergencias; 2019 Ago; 31(4):227-233. PubMed ID: 31347801 [TBL] [Abstract][Full Text] [Related]
17. One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty. Krittayaphong R; Chotinaiwatarakul C; Phankingthongkum R; Panchavinnin P; Tresukosol D; Jakrapanichakul D; Sriratanasathavorn C; Kitrattana B; Kangkagate C Am J Cardiol; 2006 Apr; 97(7):1045-50. PubMed ID: 16563913 [TBL] [Abstract][Full Text] [Related]
18. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling. Zohar P; Kovacic M; Brezocnik M; Podbregar M Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117 [TBL] [Abstract][Full Text] [Related]
19. [The immediate and long-term efficacy of electrical cardioversion in atrial fibrillation]. Frabetti L; Carioli E; Antonioli P; Ferrari G; Magnani B Cardiologia; 1993 Sep; 38(9):561-7. PubMed ID: 8287385 [TBL] [Abstract][Full Text] [Related]